Edges in Network
| Network | GSE5851_top8000 - GSE5851 - SiGN-BN NNSR |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | PRODH2 |
| Upstream (Parents) |
|---|
| (<<) APOC4 → PRODH2 |
| (<<) PLGLB1///PLGLB2 → PRODH2 |
| (<<) F7 → PRODH2 |
| Downstream (Children) |
|---|
| PRODH2 → RBMS2 (>>) |
| PRODH2 → MLXIPL (>>) |
| PRODH2 → NR4A1 (>>) |
| PRODH2 → PEBP1 (>>) |
| PRODH2 → SLC28A1 (>>) |
| PRODH2 → BDKRB2 (>>) |
| PRODH2 → HDGFRP3 (>>) |
| PRODH2 → GMEB1 (>>) |
| PRODH2 → FST (>>) |
| PRODH2 → RAB17 (>>) |
| PRODH2 → ECHS1 (>>) |
| PRODH2 → SLC25A20 (>>) |
| PRODH2 → SEPX1 (>>) |
| PRODH2 → FAM164A (>>) |
| PRODH2 → PRR5L (>>) |
| PRODH2 → INPP5D (>>) |
| PRODH2 → EVX1 (>>) |
| PRODH2 → MAFF (>>) |
| PRODH2 → RXRA (>>) |
| PRODH2 → LRRC23 (>>) |
| PRODH2 → HNRNPA3///HNRNPA3P1 (>>) |
| PRODH2 → CYP2C19 (>>) |
| PRODH2 → GPLD1 (>>) |
| PRODH2 → CFB (>>) |
| PRODH2 → ACACB (>>) |
| PRODH2 → CYB5A (>>) |
| PRODH2 → GNAO1 (>>) |
| PRODH2 → KIAA0195 (>>) |
| PRODH2 → GDF2 (>>) |
| PRODH2 → INHBC (>>) |
| PRODH2 → DECR2 (>>) |
| PRODH2 → MSRA (>>) |
| PRODH2 → AZI1 (>>) |
| PRODH2 → PAM (>>) |
| PRODH2 → PHTF2 (>>) |
| PRODH2 → GPT (>>) |
| PRODH2 → NSUN6 (>>) |
| PRODH2 → FURIN (>>) |
| PRODH2 → P4HA2 (>>) |
| PRODH2 → IRF2BP1 (>>) |
| PRODH2 → SLC2A9 (>>) |
| PRODH2 → PTH1R (>>) |
| PRODH2 → PXMP2 (>>) |
